Luliconazole CAS 187164-19-8 Puritas ≥99.0% HPLC Factory API Quality
Supple Luliconazole et intermedia Related
Luliconazole CAS 187164-19-8
(1-Imidazolyl) acetonitrile CAS 98873-55-3
(S) -2,4-Dichloro-α- (Chloromethyl) benzyl Alcohol CAS 126534-31-4
| Nomen chemicum | Iuliconazole |
| Synonyma | (2E)-2-[(4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-(1H-imidazol-1-yl)acetonitrile;NND 502 |
| CAS Number | 187164-19-8 |
| CATTUS Number | RF-API110 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C14H9Cl2N3S2 |
| M. Pondus | 354.27 |
| Liquescens punctum | 150.0 ad 154.0℃ |
| Imprimis Rotationes [a]20/D | -48.0° ad -53.0° (C=1, DMF) |
| Solubilitas | Insolubilis in aqua;Solutum in acetone;Leviter solutum in Methanolum |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Off-White ad lux Yellow Crystalline pulveris |
| Lepidium sativum IR | Specimen ultrarubrum sample debet respondere cum vexillum relationis |
| Lepidium sativum HPLC | Retentionis tempus solutionis maioris cacuminis sample solutionis correspondere debet solutioni normae quae in probatione obtinetur |
| Damnum in Siccatio | ≤0.50% |
| Residere in Ignition | ≤0.20% |
| Metalla gravia (Pb) | ≤20ppm |
| Substantiae cognatae | |
| Omnis immunditia | ≤0.20% |
| Totalis immunditias | ≤0.50% |
| RELICTUM Solvents | |
| Methanol | ≤3000ppm |
| Acetonitrile | ≤410ppm |
| Dichloromethane | ≤600ppm |
| N-Hexane | ≤290ppm |
| Ethyl Acetate | ≤5000ppm |
| Tetrahydrofuran | ≤720ppm |
| Methyl tert-Butyl Ether | ≤5000ppm |
| N-Heptane | ≤5000ppm |
| Triethylamine | ≤320ppm |
| Dimethyl Sulfoxide | ≤5000ppm |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) (ex exaruit basis) |
| Test Standard | Enterprise Standard |
| Consuetudinem | Pharmaceutical intermedia |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
Luliconazole (CAS: 187164-19-8) est thema antifungal imidazole antibioticum cum lato spectro et actui antifungal potente.Luliconazole est genus analogi lanoconazoli.Intercedere potest cum synthesi fungali parietis cellae et incrementi fungal per gradus ergosteroli decrescentes per inhibitionem lanosteroli demethylasis actionis.Praeterquam adhibita tractatione pedis athletae, pruriginis et tinnuli, etiam pro onychomycosi (unguis fungus) curatione adhibita est et nunc etiam scaenam clinicam III ingressus est.Hoc productum primum evolvit pesticide Corporation Iaponica (NihonNohyaku Co., Ltd.).Mense Novembri 2013, FDA cremor 1% luliconazole probavit ut in forum ingrediendi tractationem theologicam pedis athletae interdigitalis, prurigine et tinniens, nomine artis Luzu et primum in mercatum in America Septentrionali ingressus est.Cum mane Aprili 2005, luliconazole probatus est ingredi mercatum in Iaponia sub commercio Lulicon nomine.Mense Ianuario MMX et Iunio MMXII, probatum est de rebus in India et Sinis venalicium.
